Almirall acquires Allergan U.S. medical dermatology portfolio
21 Sep 2018 //
PR NEWSWIRE
Almirall acquires Allergan`s US dermatology portfolio for $650 million
03 Aug 2018 //
PHARMA TIMES
Teligent`s Generic Flurandrenolide Receives Approval In US
22 Dec 2016 //
FDA
Report Card: FDA Earns a Solid
25 Jan 2015 //
FDA LAW BLOG